Trial Profile
.A study to assess the effect of pre-operative capecitabine (Xeloda) combined with standard radiotherapy on clinical response rate in patients with locally advanced rectal cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Feb 2010
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary)
- Indications Rectal cancer
- Focus Therapeutic Use
- Sponsors Roche
- 23 Feb 2010 Status changed from active, no longer recruiting to completed as reported by Roche record
- 02 Jun 2006 New trial record.